Therapy News and Research

RSS

Sexual health symptoms associated with lower adherence to breast cancer therapy in Black women

Among patients with early-stage breast cancer treated with adjuvant endocrine therapy (AET), symptoms related to sexual health were associated with decreased adherence to treatment in Black women, according to results presented at the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 21-24, 2024.

21 Sep 2024

Mount Sinai expands psychedelic research center with major donation from Parsons Foundation

Mount Sinai Health System this week celebrated the opening of an expansion of its psychedelic psychotherapy research center into a new location and announced a foundational $5 million gift from The Bob & Renee Parsons Foundation.

20 Sep 2024

UTA cancer researcher elected president of the American Society for Photobiology

University of Texas at Arlington cancer researcher Sherri McFarland has been elected president of the American Society for Photobiology (ASP), a national scientific organization dedicated promoting research related to the effects of light on human health and the broader natural world.

20 Sep 2024

Stroke risk rises in patients with sickle cell disease despite established guidelines

The incidence of stroke continues to increase for adults and children living with sickle cell disease (SCD) despite the Stroke Prevention Trial in Sickle Cell Anemia (STOP) establishing standards of care like transfusions and tests to measure blood flow in the brain for those deemed high-risk, according to a study published today in Blood.

20 Sep 2024

UCLA develops largest collection of patient-derived organoids for sarcoma research

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to work for each individual patient.

20 Sep 2024

Promising antidepressant offers hope for glioblastoma treatment

Glioblastoma is a particularly aggressive brain tumor that at present is incurable. Cancer doctors can extend patients' life expectancy through operations, radiation, chemotherapy or surgical interventions. Nevertheless, half of patients die within twelve months of diagnosis.

20 Sep 2024

FUJIFILM Irvine Scientific develops Oceo Rover: The first automated single-use hydration system for media and buffers

FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced the development of Oceo Rover, a first-of-its-kind* single-use technology system, that enables manufacturers of biopharmaceuticals to improve bioprocessing workflows by automating and simplifying the hydration of media, feeds, and buffers.

From FUJIFILM Irvine Scientific 20 Sep 2024

Access to accredited hospitals improves cancer care outcomes for vulnerable patients

Vulnerable patients facing social, environmental, and economic disadvantages often experience worse cancer outcomes than other groups.

19 Sep 2024

New workflow enhances proton therapy by adapting to daily changes in cancer patients

In the treatment of cancer patients, irradiation can be adapted anew each day to the position of the tumor and conditions in the body.

19 Sep 2024

FORT-2 trial shows promising results for bladder cancer immunotherapy combination

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer.

19 Sep 2024

Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma

A team of researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and The University of Texas M.D. Anderson Cancer Center, have reported safety and efficacy results from a Phase 1 trial that featured a personalized vaccine to treat lymphoplasmacytic lymphoma, a rare and slow-growing type of blood cancer, according to a study published recently in Nature Communications.

19 Sep 2024

Researchers seek to revolutionize rectal cancer treatment with AI

With a new four-year, $1.14 million grant from the U.S. Department of Veterans Affairs, researchers at Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center, will use artificial intelligence (AI) to determine the best personalized treatment for Veterans with rectal cancer.

19 Sep 2024

Rice and Baylor receive $2.8 million to suppress inflammation and lung damage in ARDS patients

Rice University and Baylor College of Medicine have received $2.8 million in funding from the National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), for research on reducing inflammation and lung damage in acute respiratory distress syndrome (ARDS) patients.

19 Sep 2024

Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development

Asimov, the synthetic biology company advancing the design and production of therapeutics, today announced the launch of the AAV Edge System, a comprehensive suite of tools for adeno-associated viral (AAV) gene therapy design and manufacturing.

18 Sep 2024

Researchers discover how rare cell type controls scar tissue formation in spinal cord injuries

After a spinal cord injury, nearby cells quickly rush to action, forming protective scar tissue around the damaged area to stabilize and protect it.

18 Sep 2024

Drug-resistant SARS-CoV-2 variants found in immunocompromised patients

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population found researchers at Weill Cornell Medicine, the College of Veterinary Medicine at Cornell University and the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID).

18 Sep 2024

Extended estrogen suppression treatment found safe for postmenopausal breast cancer patients

New evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of coronary artery calcification, a sign of active coronary atherosclerosis, as some prior studies had indicated.

18 Sep 2024

Early intervention in pediatric-onset MS can lead to improved long-term outcomes

New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term disability in multiple sclerosis (MS) patients.

18 Sep 2024

Hemorrhages found to be more common in cancer patients than previously thought

In a recent study published in the scientific journal "Blood", researchers from MedUni Vienna show that hemorrhages are more common in cancer patients than previously thought and are associated with a poor prognosis and an increased risk of death.

18 Sep 2024

$1 million grant awarded to explore myelin repair mechanisms in multiple sclerosis

The National Multiple Sclerosis Society (USA) has awarded a grant of 1 million dollars to Dr. Isabel Pérez-Otaño, who leads the Plasticity and Remodeling of Neural Circuits laboratory at the Institute for Neurosciences (IN), a joint center of the Spanish National Research Council (CSIC) and the Miguel Hernández University (UMH) of Elche.

18 Sep 2024

Therapy News and Research

Sexual health symptoms associated with lower adherence to breast cancer therapy in Black women

Mount Sinai expands psychedelic research center with major donation from Parsons Foundation

UTA cancer researcher elected president of the American Society for Photobiology

Stroke risk rises in patients with sickle cell disease despite established guidelines

UCLA develops largest collection of patient-derived organoids for sarcoma research

Promising antidepressant offers hope for glioblastoma treatment

FUJIFILM Irvine Scientific develops Oceo Rover: The first automated single-use hydration system for media and buffers

Access to accredited hospitals improves cancer care outcomes for vulnerable patients

New workflow enhances proton therapy by adapting to daily changes in cancer patients

FORT-2 trial shows promising results for bladder cancer immunotherapy combination

Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma

Researchers seek to revolutionize rectal cancer treatment with AI

Rice and Baylor receive $2.8 million to suppress inflammation and lung damage in ARDS patients

Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development

Researchers discover how rare cell type controls scar tissue formation in spinal cord injuries

Drug-resistant SARS-CoV-2 variants found in immunocompromised patients

Extended estrogen suppression treatment found safe for postmenopausal breast cancer patients

Early intervention in pediatric-onset MS can lead to improved long-term outcomes

Hemorrhages found to be more common in cancer patients than previously thought

$1 million grant awarded to explore myelin repair mechanisms in multiple sclerosis

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News